Vorinostat in refractory soft tissue sarcomas - Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO)
详细信息    查看全文
文摘

First multi-centre trial on vorinostat in Soft Tissue Sarcoma.

Objective response to treatment was low.

A subgroup of patients experienced long-lasting disease stabilisation.

NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.